michigan semaglutide gastric intestinal obstruction class action gastrointestinal glp-1 obstruction lawsuit in michigan Glucagon-Like Peptide-1 Receptor Agonists and Gastrointestinal Adverse Events: A Systematic Review and Meta-Analysis-150cent SAGES colorectal and metabolic bariatric
Description
The first randomised controlled trial of semaglutide for alcohol use disorder, published in JAMA Psychiatry in 2025, found that people taking low doses had fewer heavy drinking days, fewer cravings, and reduced alcohol intake compared to placebo

Learn why fiber is essential when taking GLP-1 medications for weight loss

Ryan Ramos offers GLP-1 injections and personalized treatment plans

Most cases are centered in the southeastern part of Michigan, although illnesses have also been reported in Ohio, North Carolina, Illinois and New Jersey.

Learn the potential side effects, symptoms to watch for, when to seek medical advice, and how to safely manage your next dose.
